Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

This research found that the clinical outcomes (PFS, ORR, OS) of the non-platinum-based doublet regimen (docetaxel capecitabine combination) were similar to those of the platinum-based (oxaliplatin capecitabine combination) when used as first line therapy for MGC patients. BACKGROUND: Docetaxel, pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiao-Yin, Liu, Xin, Li, Wen-Hua, Qiu, Li-Xin, Huang, Ming-Zhu, Wang, Chen-Chen, Chen, Zhi-Yu, Zhang, Wen, Feng, Wan-Jing, Guo, Wei-Jian, Zhu, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643736/
https://www.ncbi.nlm.nih.gov/pubmed/36387112
http://dx.doi.org/10.3389/fonc.2022.911160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643736/
https://www.ncbi.nlm.nih.gov/pubmed/36387112
http://dx.doi.org/10.3389/fonc.2022.911160

Ejemplares similares